XTL Biopharmaceuticals Ltd. (XTLB)
Largest Insider Buys in Sector
XTLB Stock Price History Chart
XTLB Stock Performance
About XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and …
Insider Activity of XTL Biopharmaceuticals Ltd.
Over the last 12 months, insiders at XTL Biopharmaceuticals Ltd. have bought $0 and sold $0 worth of XTL Biopharmaceuticals Ltd. stock.
On average, over the past 5 years, insiders at XTL Biopharmaceuticals Ltd. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 51,000 shares for transaction amount of $164,730 was made by EDELMAN JOSEPH (10 percent owner) on 2008‑06‑10.
List of Insider Buy and Sell Transactions, XTL Biopharmaceuticals Ltd.
| 2008-11-19 | Sale | 10 percent owner | 9.6M 6.44% | $0.15 | $1.47M | +40.00% | ||
| 2008-11-18 | Sale | 10 percent owner | 30.45M 19.0502% | $0.14 | $4.34M | +7.69% | ||
| 2008-06-10 | 10 percent owner | 51,000 0.7232% | $3.23 | $164,730 | -92.26% | |||
| 2008-06-09 | 10 percent owner | 33,600 0.4956% | $3.36 | $112,896 | -92.63% | |||
| 2008-06-06 | 10 percent owner | 100,000 1.5059% | $3.43 | $343,000 | -92.84% | |||
| 2008-06-05 | 10 percent owner | 300,000 4.2453% | $3.22 | $967,000 | -92.75% | |||
| 2008-06-04 | 10 percent owner | 25,000 0.3282% | $2.99 | $74,750 | -91.61% | |||
| 2008-06-03 | 10 percent owner | 400,730 5.3307% | $3.03 | $1.21M | -91.75% | |||
| 2008-05-02 | 10 percent owner | 50,000 0.8517% | $3.88 | $194,000 | -40.41% | |||
| 2008-05-01 | 10 percent owner | 105,000 1.7287% | $3.75 | $393,750 | -40.21% | |||
| 2008-04-30 | 10 percent owner | 128,370 2.1099% | $3.74 | $480,579 | -38.42% | |||
| 2008-04-29 | 10 percent owner | 229,240 3.5606% | $3.54 | $811,028 | -37.30% | |||
| 2008-04-10 | 10 percent owner | 100,000 1.5699% | $3.58 | $357,590 | -21.02% | |||
| 2008-04-01 | 10 percent owner | 301,000 4.1792% | $3.16 | $951,913 | -2.87% | |||
| 2008-03-28 | 10 percent owner | 25,000 0.3181% | $2.90 | $72,460 | +2.34% | |||
| 2008-03-18 | 10 percent owner | 163,000 2.2329% | $3.12 | $508,593 | -1.89% | |||
| 2008-03-14 | 10 percent owner | 463,000 6.7626% | $3.33 | $1.54M | -6.55% | |||
| 2008-03-13 | 10 percent owner | 247,000 3.6626% | $3.38 | $834,234 | -9.25% | |||
| 2008-03-12 | 10 percent owner | 440,000 6.4821% | $3.36 | $1.48M | -6.40% | |||
| 2008-03-11 | 10 percent owner | 619,000 8.9963% | $3.31 | $2.05M | -5.69% |
Insider Historical Profitability
| EDELMAN JOSEPH | 10 percent owner | 20580260 170.9597% | $1.44 | 61 | 2 | |
| BENTSUR RON | CEO | 20101 0.167% | $1.44 | 2 | 0 | +144.27% |